X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sativex (84) 84
humans (62) 62
index medicus (54) 54
cannabidiol (51) 51
multiple sclerosis (49) 49
spasticity (48) 48
drug combinations (46) 46
cannabinoids (38) 38
male (37) 37
clinical neurology (35) 35
dronabinol (32) 32
female (31) 31
middle aged (30) 30
adult (28) 28
multiple sclerosis - drug therapy (26) 26
muscle spasticity - drug therapy (26) 26
muscle spasticity - etiology (24) 24
pharmacology & pharmacy (24) 24
plant extracts - therapeutic use (24) 24
multiple sclerosis - complications (23) 23
neurosciences (23) 23
double-blind (22) 22
pain (21) 21
symptoms (20) 20
treatment outcome (19) 19
cannabis-based medicine (17) 17
delta-9-tetrahydrocannabinol (17) 17
nabiximols (17) 17
care and treatment (16) 16
multiple-sclerosis (16) 16
cannabis (15) 15
marijuana (15) 15
plant extracts - adverse effects (15) 15
clinical trials (14) 14
tetrahydrocannabinol (14) 14
cannabinoid (13) 13
double-blind method (13) 13
dronabinol - administration & dosage (12) 12
neurology (12) 12
oromucosal spray (12) 12
plant extracts - administration & dosage (12) 12
controlled-trial (11) 11
drug therapy (11) 11
endocannabinoid system (11) 11
quality of life (11) 11
aged (10) 10
cannabidiol - administration & dosage (10) 10
medicine & public health (10) 10
multiple sclerosis - physiopathology (10) 10
neuropathic pain (10) 10
placebo-controlled trial (10) 10
research (10) 10
analysis (9) 9
cannabinoids - therapeutic use (9) 9
dronabinol - therapeutic use (9) 9
management (9) 9
efficacy (8) 8
cannabidiol - therapeutic use (7) 7
cannabinoids - administration & dosage (7) 7
delta-tetrahydrocannabinol (7) 7
health care sciences & services (7) 7
medicine (7) 7
pain - drug therapy (7) 7
pharmacology (7) 7
randomized controlled trials as topic (7) 7
severity of illness index (7) 7
usage (7) 7
administration, oral (6) 6
animals (6) 6
endocannabinoids (6) 6
numeric rating-scale (6) 6
oral sprays (6) 6
phytotherapy (6) 6
psychiatry (6) 6
randomized controlled-trial (6) 6
reliability (6) 6
safety (6) 6
sleep (6) 6
trial (6) 6
activities of daily living (5) 5
cannabinoid receptors (5) 5
cannabinoids - adverse effects (5) 5
clinical-practice (5) 5
health aspects (5) 5
italy (5) 5
medical research (5) 5
medicine, general & internal (5) 5
nabilone (5) 5
neuralgia - drug therapy (5) 5
neuroradiology (5) 5
patients (5) 5
pilot projects (5) 5
plant extracts - pharmacology (5) 5
scale (5) 5
thc (5) 5
cannabinoids - pharmacology (4) 4
complications and side effects (4) 4
dosage and administration (4) 4
dronabinol - adverse effects (4) 4
drugs (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
International Journal of Neuroscience, ISSN 0020-7454, 02/2019, Volume 129, Issue 2, pp. 119 - 128
Purpose/aim: To evaluate the efficacy of tetrahydrocannabinol (THC):cannabidiol (CBD) oromucosal spray (Sativex ® ) as add-on therapy to optimised standard... 
Sativex | THC:CBD | Multiple sclerosis | spasticity | nabiximols | MANAGEMENT | OROMUCOSAL SPRAY | Sativex((R)) | QUALITY-OF-LIFE | NEUROSCIENCES
Journal Article
Journal Article
Journal Article
Expert Review of Pharmacoeconomics & Outcomes Research, ISSN 1473-7167, 08/2012, Volume 12, Issue 4, pp. 439 - 441
Journal Article
Bioanalysis, ISSN 1757-6180, 04/2016, Volume 8, Issue 8, pp. 829 - 845
Sativex (R) is an oromucosal spray indicated for the treatment of moderate-to-severe spasticity in multiple sclerosis and is also an effective analgesic for... 
cannabidiol | Sativex | tetrahydrocannabinol | CHEMISTRY, ANALYTICAL | BIOCHEMICAL RESEARCH METHODS | GLUCURONIDATED CANNABINOIDS | TANDEM MASS-SPECTROMETRY | CONTROLLED SMOKED CANNABIS | ORAL FLUID | WHOLE-BLOOD | IN-VITRO STABILITY | SIMULTANEOUS QUANTIFICATION | THC/CBD OROMUCOSAL SPRAY | HUMAN URINE | Sativex (R) | SOLID-PHASE EXTRACTION
Journal Article